---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-016518"
form_type: "8-K/A"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2023-10-18T23:59:59+00:00"
generated_at: "2026-06-09T21:54:17.539586+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Olema appoints Scott Garland to board of directors with extensive launch experience

## Summary
- Scott Garland appointed to Olema's Board as Class III director effective Oct 16, 2023.
- Garland brings >30 years biopharma experience; former CEO of PACT Pharma and Portola.
- He received initial equity grants: 21,520 shares (option) vesting over 3 years, and 14,347 shares (option) vesting by 2024 annual meeting.
- Also receives annual cash retainer of $40,000 and additional $6,000 for Compensation Committee service.
- Board cites his commercial expertise as crucial as palazestrant enters Phase 3.

## SEC filing metadata
- accession: 0001558370-23-016518
- form_type: 8-K/A
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2023-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000155837023016518/0001558370-23-016518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000155837023016518/olma-20231013x8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-016518
- JSON: https://secwatch.observer/filing/0001558370-23-016518.json
- Plain text: https://secwatch.observer/filing/0001558370-23-016518.txt

## Key facts
- Executive change
  Scott Garland was appointed as Class III Director at Olema Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Class III Director
  source text: appointed Scott Garland to the Board as a Class III director, effective October 16, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1750284/000155837023016518/0001558370-23-016518-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.